parthenolide and dinoprostone

parthenolide has been researched along with dinoprostone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Ong, CN; Shen, HM; Shi, X; Won, YK1
Kozak, A; Kozak, W; Wrotek, S1
Chung, EY; Kim, BH; Kim, Y; Kim, YS; Lee, CK; Lee, JY; Min, KR; Reddy, AM; Ryu, SY; Seo, JH1
Fang, LJ; Lu, GH; Shao, XT; Wang, S; Xu, T; Zhou, JY1
Harada, T; Iwabe, T; Nakamura, K; Takai, E; Taniguchi, F; Uegaki, T1

Other Studies

6 other study(ies) available for parthenolide and dinoprostone

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
    Carcinogenesis, 2004, Volume: 25, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Celecoxib; Cell Death; Cyclooxygenase 2; Dinoprostone; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermal Cells; Female; Immunohistochemistry; Isoenzymes; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mice, Hairless; Mitogen-Activated Protein Kinases; Models, Chemical; Neoplasms, Radiation-Induced; p38 Mitogen-Activated Protein Kinases; Papilloma; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyrazoles; Sesquiterpenes; Skin Neoplasms; Sulfonamides; Time Factors; Transcription Factor AP-1; Transcription, Genetic; Transcriptional Activation; Ultraviolet Rays

2004
Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-kappaB.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2006, Volume: 290, Issue:4

    Topics: Animals; CpG Islands; Dinoprostone; DNA; Fever; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Pyrogens; Sesquiterpenes; Signal Transduction; Temperature; Toll-Like Receptors

2006
Artemisolide from Artemisia asiatica: nuclear factor-kappaB (NF-kappaB) inhibitor suppressing prostaglandin E2 and nitric oxide production in macrophages.
    Archives of pharmacal research, 2006, Volume: 29, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Artemisia; Cell Line; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Genes, Reporter; Lipopolysaccharides; Macrophages; Mice; NF-kappa B p50 Subunit; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Components, Aerial; Sesquiterpenes; Transcription Factor RelA; Transfection; Triterpenes

2006
Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.
    Planta medica, 2010, Volume: 76, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lactones; Lung Neoplasms; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Phytotherapy; Plant Extracts; Sesquiterpenes; Tanacetum

2010
Parthenolide reduces cell proliferation and prostaglandin E2 [corrected] in human endometriotic stromal cells and inhibits development of endometriosis in the murine model.
    Fertility and sterility, 2013, Volume: 100, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Gene Expression Regulation, Enzymologic; Humans; I-kappa B Proteins; Inflammation Mediators; Interleukin-8; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Phosphorylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; Stromal Cells; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2013